www.clinicalomics.com May/June 2017 Clinical OMICs 1
Cover: National Cancer Institute; Above (top right): National Cancer Institute; (top left) Thermo Fisher Scientific; (middle right) Vanderbilt
Vaccine Center; (bottom left) Thermo Fisher Scientific; (bottom right) lvcandy / Getty Images.
https://twitter.com/ClinicalOMICs
VOL. 4, Issue No. 2 May/June 2017
3 | NEWS
Rocking the Baseline
Verily, Duke and Stanford Aim to Make Medicine More
Predictive with New Baseline Study
10 | FROM THE EDITOR
Can EHRs Adapt to Share Genomic Data?
11 | OP-ED
Raising the Bar in Target Enrichment
12 | IN THE CLINIC
Data for Diagnosis: Edico Genome and Congenica to
Provide All-In-One Clinical Decision Support Package
16 | DIAGNOSTICS
Next-Gen Diagnostics: ermo Fisher
Scientific, University Hospital Basel
Partner on NGS Cancer Diagnostics
30 | DATA & INFORMATICS
Immune Investigators: Human Immunome
Program Seeks Insights on Preventing and
Controlling Disease
34 | IN THE LAB
Splicing Error Detectives: A Newly Developed
Assay Helps Identify Disease-Causing Mutations in
the Exome that Alter Gene Splicing
39 | NEW PRODUCTS
40 | PRECISION MEDICINE
For the (Electronic Health) Record:
Feds Back Pilot Project to Make
Genetic Data-Sharing More
Manageable
44 | INDUSTRY EVENTS
The Power of One
Single-Cell Genomics Targets Cancer on Its Own Terms
Sequencing the RNA of single cells is unlocking the secrets
of tumor heterogeneity and opening doors to better cancer
diagnostics and targeted therapies.
Massive Potential
As mass spectrometry's accuracy and specificity
improves, it breaks new ground in proteomics,
metabolomics, and diagnostics.
20
26